[ce document de référence de l'OMS est disponible à cet adresse: www.who.int/druginformation
voir page 350
"Artemisinin-based malaria treatment approved European Union The European Medicines Agency (EMA) has recommended approval of Eurartesim®, a fixed combination product consisting of dihydroartemisinin
and piperaquine phosphate. Eurartesim® is intended for the treatment of uncomplicated Plasmodium falciparum malaria in adults, children and infants
aged 6 months or over and weighing 5 kg or more.
CB]